Walmart Allergy Relief D Extended-Release Tablets Recalled for Failed Dissolution
Dr. Reddy's Laboratories is recalling Walmart brand Allergy Relief D extended-release tablets (Lot #AC2103329B) nationwide because the tablets failed to meet dissolution specifications, which may affect medication effectiveness.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall for a manufacturing/quality defect (failed dissolution specifications) with no reported illnesses or injuries. The hazard is theoretical—potential reduced efficacy—making this a precautionary recall appropriate for a Moderate severity rating.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling Allergy Relief D Fexofenadine HCl 60 mg / Pseudoephedrine HCl 120 mg Extended-Release Tablets, USP, distributed by Walmart Inc. The recall affects 9,984 cartons of 30-tablet bottles (NDC 49035-273-30) distributed nationwide in the USA.
The recall was initiated because the tablets failed to meet dissolution specifications. Dissolution specifications ensure that medication dissolves properly in the body at the intended rate, allowing the active ingredients to be absorbed as designed.
Consumers who have purchased this product should stop using it and consult their healthcare provider or pharmacist about obtaining a replacement or alternative medication. The affected lot number is AC2103329B, and the product was manufactured in India.
The recalled product
- Product
- Allergy Relief D Fexofenadine HCl, 60 mg I Pseudoephedrine HCl, 120 mg, Extended Release Tablets, USP, 30 Extended-Release Tablets USP, Distributed By Walmart Inc., Bentonville, AR 72716, Product of India, NDC 49035-273-30.
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Category
- Drug — Allergy / Decongestant
- Affected units
- 9,984
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: AC2103329B
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 9 recalled by Dr. Reddy's Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 9 products in this recall →Related recalls
Same manufacturer · Dr. Reddy's Laboratories, Inc.
See all →- ModerateVarenicline tablets recalled after an assay value fell below specification
FDA (Drugs) · 2025-12-17
- Moderate
- HighOmeprazole capsule bottle contained a foreign divalproex sodium tablet
FDA (Drugs) · 2025-07-23
- SevereLevetiracetam Injection Label Mismatch Nationwide Recall
FDA (Drugs) · 2025-04-23
- ModerateFDA Recalls JAVYGTOR Tablets Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2024-12-18
Same hazard · dissolution failure
See all →- ModerateApotex Recalls Paroxetine Hydrochloride Extended-Release Tablets for Dissolution Failure
FDA (Drugs) · 2026-10-07
- ModerateAjanta Pharma Recalls Ranolazine Tablets for Dissolution Failure
FDA (Drugs) · 2026-10-07
- ModerateMylan Recalls Mycophenolate Mofetil Injection Due to Dissolution Failures
FDA (Drugs) · 2026-09-09
- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateMylan Recalls Acamprosate Calcium Tablets Due to Dissolution Failure
FDA (Drugs) · 2026-08-26
Similar recalls
- ModerateAllergy Relief D tablets recalled for failed dissolution specifications
FDA (Drugs) · 2022-12-07
- ModerateEquate Allergy Relief D Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-01-26
- LowWal-Fex D Allergy and Decongestant Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-01-26
- ModerateQC Quality Choice Fexofenadine/Pseudoephedrine Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-01-26
- ModerateFexofenadine/Pseudoephedrine tablets recalled for failed dissolution
FDA (Drugs) · 2022-01-26
- ModerateCVS Health Allergy Relief D Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-01-26